Close

UPDATE: Oppenheimer Starts Advisory Board Company (ABCO) at Outperform

June 18, 2015 6:37 AM EDT
Get Alerts ABCO Hot Sheet
Price: $53.83 --0%

Rating Summary:
    7 Buy, 11 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
(Updated - June 18, 2015 8:37 AM EDT)

Oppenheimer initiated coverage on Advisory Board Company (NASDAQ: ABCO) with an Outperform rating and a price target of $65. Analyst Mohan Naidu noted the company's strengthening position in healthcare and higher ed.

"ABCO has strengthened its position in the healthcare industry as the go-to advisor for providers, with a significant depth of expertise in healthcare. The company’s unique research and software solution continues to be a big differentiator which we believe is key to its sustainable growth. Further, we believe the changing healthcare environment bodes very well for long-term growth," said Naidu.

"Near term, providers' push into value-based programs should drive demand for the company’s solutions, especially around pop health. While the Royall acquisition has added some noise to the numbers, we believe the expedited entry into the higher education segment is a timely way to take advantage of that industry’s changing dynamics," added the analyst.

For an analyst ratings summary and ratings history on Advisory Board Company click here. For more ratings news on Advisory Board Company click here.

Shares of Advisory Board Company closed at $52.38 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS View, New Coverage

Related Entities

Definitive Agreement